Partin reported predictive information for a male with clinically localized prostate cancer. This can help to predict the extent of disease at radical prostatectomy. The authors are from the Johns Hopkins University and the National Institute of Aging.
Patient selection: male with clinically localized prostate cancer
Parameters:
(1) T code from T1a to T3a
(2) serum PSA in ng/mL
(3) Gleason score
OC = organ confined
ECE = extracapsular extension
SV = seminal vesicle involvement
LN = lymph node metastases
NOTES:
(1) A summation of values in each column at a given level may exceed 100.
(2) There is no T1c.
T Code |
PSA |
GS |
OC |
ECE |
SV+ |
LN+ |
T1a |
0 to 4.0 |
2 to 4 |
100 |
0 |
0 |
0 |
|
|
5 |
100 |
0 |
0 |
0 |
|
|
6 |
100 |
0 |
0 |
0 |
|
|
7 |
- |
- |
- |
- |
|
|
8 to 10 |
- |
- |
- |
- |
|
4.1 to 10 |
2 to 4 |
100 |
0 |
0 |
0 |
|
|
5 |
100 |
0 |
0 |
0 |
|
|
6 |
100 |
0 |
0 |
0 |
|
|
7 |
100 |
0 |
0 |
0 |
|
|
8 to 10 |
- |
- |
- |
- |
|
10.1 to 20 |
2 to 4 |
100 |
0 |
0 |
0 |
|
|
5 |
100 |
0 |
0 |
0 |
|
|
6 |
- |
- |
- |
- |
|
|
7 |
- |
- |
- |
- |
|
|
8 to 10 |
- |
- |
- |
- |
|
> 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
- |
- |
- |
- |
|
|
6 |
- |
- |
- |
- |
|
|
7 |
- |
- |
- |
- |
|
|
8 to 10 |
- |
- |
- |
- |
T1b |
0 to 4.0 |
2 to 4 |
85 |
15 |
1 |
2 |
|
|
5 |
78 |
22 |
3 |
4 |
|
|
6 |
68 |
30 |
6 |
8 |
|
|
7 |
54 |
43 |
12 |
15 |
|
|
8 to 10 |
- |
- |
- |
- |
|
4.1 to 10 |
2 to 4 |
78 |
22 |
2 |
2 |
|
|
5 |
70 |
29 |
4 |
4 |
|
|
6 |
53 |
45 |
9 |
9 |
|
|
7 |
39 |
58 |
18 |
18 |
|
|
8 to 10 |
32 |
64 |
29 |
30 |
|
10.1 to 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
49 |
49 |
7 |
5 |
|
|
6 |
36 |
62 |
15 |
11 |
|
|
7 |
24 |
73 |
28 |
21 |
|
|
8 to 10 |
11 |
87 |
55 |
41 |
|
> 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
- |
- |
- |
- |
|
|
6 |
- |
- |
- |
- |
|
|
7 |
- |
- |
- |
- |
|
|
8 to 10 |
- |
- |
- |
- |
T2a |
0 to 4.0 |
2 to 4 |
88 |
14 |
1 |
1 |
|
|
5 |
81 |
20 |
2 |
2 |
|
|
6 |
72 |
29 |
5 |
3 |
|
|
7 |
61 |
39 |
9 |
7 |
|
|
8 to 10 |
48 |
50 |
17 |
13 |
|
4.1 to 10 |
2 to 4 |
83 |
19 |
1 |
1 |
|
|
5 |
73 |
28 |
3 |
2 |
|
|
6 |
62 |
38 |
6 |
4 |
|
|
7 |
51 |
49 |
12 |
8 |
|
|
8 to 10 |
39 |
59 |
22 |
15 |
|
10.1 to 20 |
2 to 4 |
61 |
40 |
3 |
1 |
|
|
5 |
58 |
43 |
5 |
2 |
|
|
6 |
44 |
56 |
11 |
5 |
|
|
7 |
36 |
64 |
19 |
9 |
|
|
8 to 10 |
29 |
70 |
29 |
17 |
|
> 20 |
2 to 4 |
20 |
80 |
12 |
2 |
|
|
5 |
32 |
68 |
11 |
3 |
|
|
6 |
14 |
86 |
35 |
9 |
|
|
7 |
18 |
80 |
31 |
11 |
|
|
8 to 10 |
3 |
97 |
81 |
35 |
T2b |
0 to 4.0 |
2 to 4 |
76 |
26 |
2 |
2 |
|
|
5 |
67 |
34 |
4 |
4 |
|
|
6 |
54 |
46 |
9 |
9 |
|
|
7 |
41 |
59 |
17 |
18 |
|
|
8 to 10 |
31 |
68 |
0 |
32 |
|
4.1 to 10 |
2 to 4 |
67 |
34 |
3 |
2 |
|
|
5 |
56 |
45 |
6 |
5 |
|
|
6 |
44 |
56 |
11 |
11 |
|
|
7 |
32 |
68 |
22 |
20 |
|
|
8 to 10 |
22 |
77 |
38 |
35 |
|
10.1 to 20 |
2 to 4 |
52 |
49 |
4 |
3 |
|
|
5 |
43 |
58 |
8 |
6 |
|
|
6 |
28 |
73 |
19 |
13 |
|
|
7 |
19 |
81 |
33 |
24 |
|
|
8 to 10 |
14 |
86 |
50 |
40 |
|
> 20 |
2 to 4 |
7 |
94 |
30 |
7 |
|
|
5 |
- |
- |
- |
- |
|
|
6 |
11 |
90 |
40 |
18 |
|
|
7 |
4 |
96 |
73 |
44 |
|
|
8 to 10 |
1 |
99 |
93 |
76 |
T2c |
0 to 4.0 |
2 to 4 |
82 |
17 |
2 |
4 |
|
|
5 |
73 |
26 |
4 |
8 |
|
|
6 |
60 |
38 |
9 |
17 |
|
|
7 |
46 |
50 |
17 |
31 |
|
|
8 to 10 |
- |
- |
- |
- |
|
4.1 to 10 |
2 to 4 |
71 |
27 |
3 |
5 |
|
|
5 |
64 |
34 |
6 |
10 |
|
|
6 |
48 |
49 |
12 |
19 |
|
|
7 |
37 |
59 |
23 |
34 |
|
|
8 to 10 |
25 |
71 |
40 |
53 |
|
10.1 to 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
37 |
61 |
12 |
13 |
|
|
6 |
37 |
59 |
17 |
22 |
|
|
7 |
24 |
73 |
33 |
39 |
|
|
8 to 10 |
15 |
82 |
53 |
59 |
|
> 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
3 |
97 |
29 |
29 |
|
|
6 |
4 |
96 |
53 |
53 |
|
|
7 |
5 |
95 |
62 |
62 |
|
|
8 to 10 |
2 |
97 |
73 |
73 |
T3a |
0 to 4.0 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
- |
- |
- |
- |
|
|
6 |
42 |
59 |
8 |
15 |
|
|
7 |
- |
- |
- |
- |
|
|
8 to 10 |
- |
- |
- |
- |
|
4.1 to 10 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
43 |
58 |
5 |
8 |
|
|
6 |
33 |
68 |
11 |
16 |
|
|
7 |
26 |
75 |
18 |
28 |
|
|
8 to 10 |
12 |
87 |
40 |
50 |
|
10.1 to 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
26 |
75 |
11 |
11 |
|
|
6 |
19 |
82 |
18 |
20 |
|
|
7 |
14 |
86 |
31 |
35 |
|
|
8 to 10 |
9 |
92 |
49 |
54 |
|
> 20 |
2 to 4 |
- |
- |
- |
- |
|
|
5 |
- |
- |
- |
- |
|
|
6 |
5 |
95 |
31 |
31 |
|
|
7 |
3 |
98 |
55 |
55 |
|
|
8 to 10 |
2 |
98 |
65 |
65 |
Specialty: Hematology Oncology